Inotek pharmaceuticals stock price

Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete ... Rocket Pharmaceuticals and Inotek Pharmaceuticals complete merger transaction.

ITEK Stock News and Price / Inotek Pharmaceuticals ... SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Inotek Pharmaceuticals Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 45780V102 (CUSIP Number) Robert Atchinson Adage Capital Partners GP, L.L.C. 200 Clarendon Stock Analysis for Inotek Pharmaceuticals Corporation (ITEK) Jan 22, 2018 · No changes to the price of Inotek Pharmaceuticals Corporation in the last trading day ( Monday, 22nd Jan 2018 ). During the day the stock fluctuated 0.00% from a day low at $3.04 to a day high of $3.04.The price has been going up and down for this period, and … Quarterly Report (10-q) ITEK Inotek Pharmaceuticals Corp. (delisted) Quarterly Report (10-q) If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Today's Research Reports on Biotech Stocks to Watch ...

Mar 15, 2020 · Real time Inotek Pharmaceuticals (ITEK) stock price quote, stock graph, news & analysis. ITEK Stock | INOTEK PHARMACEUTICALS Stock Price Today ... ITEK: Get the latest Inotek Pharmaceuticals stock price and detailed information including ITEK news, historical charts and realtime prices. ITEK Inotek Pharmaceuticals — Stock Price and Discussion ... Jan 04, 2018 · Real-time trade and investing ideas on Inotek Pharmaceuticals ITEK from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk,

Investor Overview | Rocket Pharmaceuticals, Inc.

Stock analysis for Rocket Pharmaceuticals Inc (ITEK) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ITEK | HAN-GINS Innovative Technologies UCITS ETF Overview ... ITEK | A complete HAN-GINS Innovative Technologies UCITS ETF exchange traded fund overview by MarketWatch. View the latest ETF prices and news for better ETF investing. Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Stock ... Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete ...

FORUM Pharmaceuticals Inc - Company Profile and News ...

Inotek Pharmaceuticals Company Profile: Acquisition ... Information on acquisition, funding, cap tables, investors, and executives for Inotek Pharmaceuticals. Use the PitchBook Platform to explore the full profile. FORUM Pharmaceuticals Inc - Company Profile and News ... Company profile page for FORUM Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information. Benzinga | Stock Market Quotes, Business News, Financial ...

ITEK: Inotek Pharmaceuticals Corporation Stock

Today's Research Reports on Biotech Stocks to Watch ... Mar 13, 2017 · The market cap for the stock is at $360 million, and recently analysts at Stifel Nicolaus raise price target from $5.00 to $7.00 in and has "hold" rating on the firm. Consensus of analysts has Inotek Pharmaceuticals Corporation Announces Pricing of ... LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (the “Company”) today announced the pricing of its initial public offering of 6,667,000 shares of its common stock at a Inotek Pharmaceuticals Corp. - NASDAQ:ITEK - Stock Quote ... View detailed financial information, real-time news, videos, quotes and analysis on Inotek Pharmaceuticals Corp. (NASDAQ:ITEK). Explore commentary on Inotek …

Inotek Pharma (ITEK) to Merge with Rocket Pharmaceuticals Article Related Press Releases ( 1 ) Related Articles ( 2 ) Stock Quotes (1) Comments (0) FREE Breaking News Alerts from StreetInsider.com! Board of Directors | Rocket Pharmaceuticals Mr. Boess has served as a director of Inotek / Rocket Pharmaceuticals since January 2016. His most recent role has been EVP Corporate Affairs at Kiniksa Pharmaceuticals, a publicly traded biotechnology company.He previously served as Senior Vice President and Chief Financial Officer at Synageva Biopharma Corporation from 2011 until the company’s acquisition by Alexion Pharmaceuticals in 2015. ITEK - Inotek Pharma Stock Profile - Barchart.com